Sciwind, a developer of biologics, has secured $37 million in Series B financing. LYFE Capital led the round with participation from Legend Capital and Haibang Venture Capital.
Source: Press Release
Sciwind rakes in $37m Series B
Sciwind, a developer of biologics, has secured $37 million in Series B financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: